Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome

Annals of Human Genetics

Volumn 74, Issue 1, 2010, Pages 17-26

  Sullivan, Maren ^a   Erlic, Zoran ^a   Hoffmann, Michael M ^b   Arbeiter, Klaus ^c   Patzer, Ludwig ^d   Budde, Klemens ^e   Hoppe, Bernd ^f   Zeier, Martin ^g   Lhotta, Karl ^h   Rybicki, Lisa A ⁱ   Bock, Andreas ^j   Berisha, Gani ^a   Neumann, Hartmut P H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h GENERAL HOSPITAL KLAGENFURT   (Austria)

ⁱ TAUSSIG CANCER INSTITUTE   (United States)

^j CANTONAL HOSPITAL AARAU   (Switzerland)

more..

Author keywords

CD46; Complement factor H (CFH); Complement factor I (CFI); Hemolytic uremic syndrome

Indexed keywords

COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN 1; COMPLEMENT FACTOR H RELATED PROTEIN 2; COMPLEMENT FACTOR H RELATED PROTEIN 3; COMPLEMENT FACTOR H RELATED PROTEIN 4; COMPLEMENT FACTOR H RELATED PROTEIN 5; COMPLEMENT FACTOR I; DNA; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE REGISTRY; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; GERMANY; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOGENESIS; PENETRANCE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RELATIVE; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTIGENS, CD46; CHILD; CHILD, PRESCHOOL; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PENETRANCE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS;

EID: 72549097037     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2009.00554.x     Document Type: Article

References (34)

1. Agarwal A, Mauer S M, Matas A J, Nath K A. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management. J Am Soc Nephrol 1995, 6:1160-1169.
2. Artz M A, Steenbergen E J, Hoitsma A J, Monnens L A, Wetzels J F. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation 2003, 76:821-826.
3. Bettinaglio P, Galbusera A, Caprioli J, Orisio S, Perna A, Arnoldi F, Bucchioni S, Noris M. Single Strand Conformation Polymorphism (SSCP) as a quick and reliable method to genotype M235T polymorphism of angiotensinogen gene. Clin Biochem 2002, 35:363-368.
4. Caprioli J, Bettinaglio P, Zipfel P F, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001, 12:297-307.
5. Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, Mele C, Bresin E, Cassis L, Gamba S, Porrati F, Bucchioni S, Monteferrante G, Fang C J, Liszewski M K, Kavanagh D, Atkinson J P, Remuzzi G. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006, 108:1267-1279.
6. Conlon P J, Brennan D C, Pfaf W W, Finn W F, Gehr T, Bollinger R R, Smith S R. Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. Nephrol Dial Transplant 1996, 11:1810-1814.
7. Delvaeye M, Noris M, De Vriese A, Esmon C T, Esmon N L, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway E M. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009, 361:345-357.
8. Esparza-Gordillo J, Goicoechea De Jorge E, Buil A, Carreras Berges L, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez De Cordoba S. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 2005, 14:703-712.
9. Fang C J, Richards A, Liszewski M K, Kavanagh D, Atkinson J P. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 2008, 143:336-348.
10. Flicek P, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y, Clarke L, Coates G, Cunningham F, Cutts T, Down T, Dyer S C, Eyre T, Fitzgerald S, Fernandez-Banet J, Gräf S, Haider S, Hammond M, Holland R, Howe KL, Howe K, Johnson N, Jenkinson A, Kähäri A, Keefe D, Kokocinski F, Kulesha E, Lawson D, Longden I, Megy K, Meidl P, Overduin B, Parker A, Pritchard B, Prlic A, Rice S, Rios D, Schuster M, Sealy I, Slater G, Smedley D, Spudich G, Trevanion S, Vilella A J, Vogel J, White S, Wood M, Birney E, Cox T, Curwen V, Durbin R, Fernandez-Suarez X M, Herrero J, Hubbard T J, Kasprzyk A, Proctor G, Smith J, Ureta-Vidal A, Searle S. ENSEMBL 2008. Nucleic Acids Res 2008, 36:D707-714.
11. Fremeaux-Bacchi V, Dragon-Durey M A, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman W H. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004, 41:e84.
12. Fremeaux-Bacchi V, Kemp E J, Goodship J A, Dragon-Durey M A, Strain L, Loirat C, Deng H W, Goodship T H. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 2005, 42:852-856.
13. Fremeaux-Bacchi V, Miller E C, Liszewski M K, Strain L, Blouin J, Brown A L, Moghal N, Kaplan B S, Weiss R A, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault De Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey M A, Fridman W H, Janssen B J, Goodship T H, Atkinson J P. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008, 112:4948-4952.
14. Fremeaux-Bacchi V, Moulton E A, Kavanagh D, Dragon-Durey M A, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman W H, Loirat C, Atkinson J P. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006, 17:2017-2025.
15. George J N. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006, 354:1927-1935.
16. Goicoechea De Jorge E, Harris C L, Esparza-Gordillo J, Carreras L, Arranz E A, Garrido C A, Lopez-Trascasa M, Sanchez-Corral P, Morgan B P, Rodriguez De Cordoba S. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2007, 104:240-245.
17. Heinen S, Sanchez-Corral P, Jackson M S, Strain L, Goodship J A, Kemp E J, Skerka C, Jokiranta T S, Meyers K, Wagner E, Robitaille P, Esparza-Gordillo J, Rodriguez De Cordoba S, Zipfel P F, Goodship T H. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat 2006, 27:292-293.
18. Kaplan B S, Meyers K E, Schulman S L. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 1998, 9:1126-1133.
19. Kavanagh D, Kemp E J, Mayland E, Winney R J, Duffield J S, Warwick G, Richards A, Ward R, Goodship J A, Goodship T H. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005, 16:2150-2155.
20. Kavanagh D, Richards A, Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 2008, 59:293-309.
21. Lahlou A, Lang P, Charpentier B, Barrou B, Glotz D, Baron C, Hiesse C, Kreis H, Legendre C, Bedrossian J, Mougenot B, Sraer J D, Rondeau E. Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF). Medicine (Baltimore) 2000, 79:90-102.
22. Miller R B, Burke B A, Schmidt W J, Gillingham K J, Matas A J, Mauer M, Kashtan C E. Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report. Nephrol Dial Transplant 1997, 12:1425-1430.
23. Neumann H P, Salzmann M, Bohnert-Iwan B, Mannuelian T, Skerka C, Lenk D, Bender B U, Cybulla M, Riegler P, Konigsrainer A, Neyer U, Bock A, Widmer U, Male D A, Franke G, Zipfel P F. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet 2003, 40:676-681.
24. Ng P C, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006, 7:61-80.
25. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 2003, 362:1542-1547.
26. Rey-Campos J, Rubinstein P, Rodriguez De Cordoba S. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med 1988, 167:664-669.
27. Richards A, Buddles M R, Donne R L, Kaplan B S, Kirk E, Venning M C, Tielemans C L, Goodship J A, Goodship T H. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 2001, 68:485-490.
28. Richards A, Kemp E J, Liszewski M K, Goodship J A, Lampe A K, Decorte R, Muslumanoglu M H, Kavucku S, Filler G, Pirson Y, Wen L S, Atkinson J P, Goodship T H. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A 2003, 100:12966-12971.
29. Rock G A, Shumak K H, Buskard N A, Blanchette V S, Kelton J G, Nair R C, Spasoff R A. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991, 325:393-397.
30. Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes A M, Goicoechea E, Lopez-Trascasa M, De Cordoba S R. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 2002, 71:1285-1295.
31. Saunders R E, Goodship T H, Zipfel P F, Perkins S J. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 2006, 27:21-30.
32. Vyse T J, Morley B J, Bartok I, Theodoridis E L, Davies K A, Webster A D, Walport M J. The molecular basis of hereditary complement factor I deficiency. J Clin Invest 1996, 97:925-933.
33. Warwicker P, Goodship T H, Donne R L, Pirson Y, Nicholls A, Ward R M, Turnpenny P, Goodship J A. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998, 53:836-844.
34. Xiao W, Oefner P J. Denaturing high-performance liquid chromatography: A review. Hum Mutat 2001, 17:439-474.